With each new study.

Related StoriesMD Anderson study reveals why chemotherapy medicines not effective for many pancreatic cancer patientsResearch shows link between lack of RB protein and long-term survival prices in lung malignancy patientsNew results reveal association between colorectal cancer and melanoma drug treatmentThe phase III trial, which was sponsored by the Eastern Cooperative Oncology Group , enrolled 823 sufferers from seven different sites in the united states over 34 months. The primary goal of the scholarly study was to determine whether the addition of sorafenib, a molecular targeting agent, would improve survival prices for patients with metastatic melanoma when added to the chemotherapy combination of carboplatin and paclitaxel. Patients either received the chemotherapy combination alone or with sorafenib.The Kaiser Family members Foundation’s Jackie Judd spoke with Paul De Lay, UNAIDS director of evaluation and monitoring, about the record. The interview are available here. This article is certainly republished with kind authorization from our friends at the The Kaiser Family members Foundation. You will see the complete Kaiser Daily Health Plan Statement, search the archives, or join email delivery of in-depth coverage of wellness policy developments, discussions and debates. The Kaiser Daily Wellness Policy Report is published for Kaisernetwork.org, a free services of The Henry J. Kaiser Family Foundation. Copyright 2006 Advisory Board Firm and Kaiser Family Base. All rights reserved.

After campus shooting in Oregon, University of Texas professors demand their students remain defenseless from attacks In the wake of the latest campus shooting at Umpqua Community College in Roseburg, Oregon, Texas decided to join seven various other states in allowing college students to carry concealed weapons to class, within their dormitories and in campus, in both private and public schools throughout the continuing state.